This is a type of cancer that starts in the ducts within the pancreas, the gland behind your stomach. It's the most common type of pancreatic cancer.
Every report comes from a Lived member, sent anonymously.
Have you tried Gemcitabine for Pancreatic Ductal Carcinoma?
Pancreatic ductal carcinoma, usually called pancreatic ductal adenocarcinoma, is the most common form of pancreatic cancer. It begins in the cells lining the small ducts that carry digestive juices through the pancreas, a gland that sits behind the stomach. The pancreas makes enzymes that help break down food and hormones such as insulin that control blood sugar. This cancer arises in the digestive-juice (exocrine) part of the gland, not in the hormone-making cells. It matters because it is one of the hardest cancers to find early. Early tumors usually cause no symptoms, and the pancreas lies deep in the abdomen where a routine exam cannot feel it. By the time symptoms appear, the cancer has often grown large or spread. Common signs include yellowing of the skin and eyes (jaundice), dark urine, pale or greasy stools, itchy skin, pain in the upper belly or back, loss of appetite, unintended weight loss and fatigue. Some people develop diabetes or a blood clot in a leg vein before the cancer is found. Where the tumor sits shapes how it shows up. Cancers in the head of the pancreas lie next to the bile duct and can block the flow of bile, causing jaundice while the tumor is still fairly small. Cancers in the body or tail tend to cause pain instead and are more often found after they have spread. Pancreatic neuroendocrine tumors, which start in the hormone-making cells, are a different disease with a different outlook and treatment.
There is no single known cause. Pancreatic cancer develops as cells collect genetic changes over time, and several factors make that more likely. Smoking is one of the most important: people who smoke have about twice the risk of people who have never smoked, and the risk falls after quitting. Excess body weight, type 2 diabetes and chronic pancreatitis (long-term inflammation of the pancreas, often linked to heavy alcohol use and smoking) also raise risk. Heavy workplace exposure to certain chemicals used in dry cleaning and metalworking may contribute. Age is the strongest risk factor that cannot be changed. Almost everyone diagnosed is older than 45, and the average age at diagnosis is about 70. Inherited gene changes account for up to about 10% of cases, including changes in the BRCA1 and BRCA2 genes (best known for raising breast and ovarian cancer risk), the related PALB2 and ATM genes, Lynch syndrome and several rarer syndromes. A family history raises risk, but most people with this cancer have no relatives who had it, and most people with a risk factor never develop it. The link with diabetes runs in both directions. Long-standing diabetes raises risk, but the tumor itself can also damage the insulin-making cells, so diabetes or rising blood sugar is sometimes an early effect of the cancer rather than a cause.
Diagnosis usually starts with symptoms such as jaundice, pain or weight loss, a physical exam and blood tests. Liver tests help show whether jaundice comes from a blocked bile duct rather than disease in the liver itself. A CT scan with contrast dye, often a special multiphase or pancreas protocol scan, is the main imaging test because it shows the tumor clearly and whether it has spread. MRI, endoscopic ultrasound (an ultrasound probe on a thin, flexible tube passed through the mouth into the stomach and small intestine) and sometimes a PET scan add detail. A biopsy, in which a small tissue sample is examined under a microscope, confirms the diagnosis. It is often taken with a fine needle during endoscopic ultrasound. A biopsy is needed before any chemotherapy or radiation given ahead of surgery. When imaging shows a tumor that can clearly be removed, the surgeon may instead confirm the diagnosis on the tissue taken out during the operation. Staging answers the question that matters most for treatment: can the tumor be completely removed? Doctors describe it as resectable (removable), borderline resectable (removal may be possible but is uncertain, so treatment usually starts with chemotherapy), locally advanced (not removable because of how it has grown around nearby structures, though it has not spread far) or metastatic (spread to the liver, lungs or other distant organs). A blood test for CA 19-9, a protein many of these tumors release, is often measured. It cannot diagnose or rule out pancreatic cancer on its own, because other conditions can raise it and it is not high in everyone with the cancer. When it is raised, following the level over time helps show whether treatment is working or the cancer has returned. Genetic counseling and testing are often suggested after diagnosis. An inherited change such as BRCA can open specific treatment options and matters for relatives, and testing the tumor itself can occasionally find changes that point to targeted drugs.
Treatment depends mainly on the stage and on a person's overall health and strength. It is best planned by a team that includes surgeons, medical and radiation oncologists, and specialists in nutrition and symptom care. Surgery offers the only realistic chance of cure, but only about one in five people have a tumor that can be removed when they are diagnosed. The usual operation for a tumor in the head of the pancreas is the Whipple procedure (pancreaticoduodenectomy), which removes the head of the pancreas, part of the small intestine and bile duct, the gallbladder and nearby lymph nodes, then reconnects the digestive tract. Tumors in the body or tail are removed with a distal pancreatectomy, which usually takes the spleen too, so vaccines are given beforehand. These are major operations with a real risk of serious complications, and results are better at hospitals and with surgeons that perform many of them. Even when surgery removes all visible cancer, cells have often already spread unseen, so chemotherapy is given before surgery, after it, or both, usually for three to six months in total. People fit enough for it typically receive a combination such as FOLFIRINOX (fluorouracil, leucovorin, irinotecan and oxaliplatin) or gemcitabine with capecitabine, a chemotherapy pill. A single drug is used for people who would not tolerate a combination. Radiation combined with chemotherapy (chemoradiation) is used in some situations. When the cancer cannot be removed or has spread, chemotherapy is the main treatment. It aims to slow the cancer, ease symptoms and extend life. The stronger combinations, such as FOLFIRINOX, NALIRIFOX or gemcitabine with nab-paclitaxel, suit people who are fit enough to manage more side effects. In a large trial of people with untreated metastatic cancer, the median survival (the point by which half had died and half were still alive) was about 11 months with NALIRIFOX and 9 months with gemcitabine and nab-paclitaxel. Common side effects of these drugs include fatigue, nausea, diarrhea, numbness or tingling in the hands and feet, and a higher chance of infection from low white blood cell counts. People with an inherited BRCA change whose cancer has responded to platinum-based chemotherapy may then take olaparib, a targeted pill called a PARP inhibitor, which can delay regrowth, though it has not been shown to extend overall survival. Clinical trials are appropriate at every stage. Care for symptoms runs alongside cancer treatment from the start. A small tube called a stent, usually placed through an endoscope, can reopen a bile duct blocked by the tumor and relieve jaundice. Pain can usually be controlled with medicines, and a celiac plexus nerve block (an injection that numbs the nerves around the pancreas) can give lasting relief for some people. Pancreatic enzyme capsules taken with food improve digestion, and palliative care and psychological support help with comfort, mood and planning.
The outlook depends heavily on the stage at diagnosis. Among people diagnosed in the United States from 2015 to 2021, the five-year relative survival rate (how likely people were to be alive five years later compared with people without the cancer) was about 44% when the cancer was confined to the pancreas, 17% when it had reached nearby tissues or lymph nodes and 3% when it had spread to distant organs, or 13% across all stages. These figures describe large groups treated years ago, so they cannot predict any one person's course, and treatment has improved since. Treatment is demanding. Surgery means a substantial recovery, and afterward many people deal with slow stomach emptying, changes in bowel habits, weight loss and sometimes new diabetes that needs treatment. Chemotherapy is given in cycles, most often two or three weeks long, usually through an IV, often by a central line or port placed under the skin. Fatigue and appetite loss can make work and daily routines harder for long stretches. Nutrition is a daily concern at every stage. The cancer and its treatment often cause weight loss and poor digestion, and many people need pancreatic enzyme capsules with food. A dietitian can help maintain weight, and for serious problems a temporary feeding tube is sometimes used. After treatment aimed at cure, follow-up visits with scans and blood tests are often scheduled about every three months for the first couple of years and then about every six months, because the cancer frequently returns. For people living with cancer that cannot be removed, care focuses on keeping it in check as long as possible while protecting comfort and quality of life. Talking early about goals and preferences, and drawing on support for caregivers, helps many families manage a disease that can change quickly.
Get prompt medical evaluation for yellowing of the skin or eyes, especially with dark urine, pale or greasy stools or itching. Jaundice always needs a cause found, even though gallstones, hepatitis and other liver problems are more common causes than cancer. Unexplained weight loss, a lasting loss of appetite, or new pain in the upper belly or back that does not settle also deserve an appointment. During treatment, call the care team right away for a fever of 100.5°F (38°C) or higher or chills while on chemotherapy, jaundice that returns after a stent has been placed, a leg that becomes swollen, painful, red or warm, or pain that is not controlled. Call 911 for sudden shortness of breath, chest pain, coughing up blood or fainting, which can signal a blood clot that has traveled to the lungs (pulmonary embolism), a known risk with this cancer.
Last reviewed • Oct 2026
Educational content, not medical advice.
Share what living with Pancreatic Ductal Carcinoma is like, what's helped you, or ask the community a question.